Hydroxyethyl starch 6% 130/0.4
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hydroxyethyl starch 6% 130/0.4, covering 2014-12-03 to 2023-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients [Phase 3]